131 related articles for article (PubMed ID: 37772892)
21. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238
[TBL] [Abstract][Full Text] [Related]
22. PEGylated solid lipid nanoparticles functionalized by aptamer for targeted delivery of docetaxel in mice bearing C26 tumor.
Shakib Z; Mahmoudi A; Moosavian SA; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2022 Feb; 48(2):69-78. PubMed ID: 35758194
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronic acid targeted and pH-responsive nanocarriers based on hollow mesoporous silica nanoparticles for chemo-photodynamic combination therapy.
Chen K; Chang C; Liu Z; Zhou Y; Xu Q; Li C; Huang Z; Xu H; Xu P; Lu B
Colloids Surf B Biointerfaces; 2020 Oct; 194():111166. PubMed ID: 32521461
[TBL] [Abstract][Full Text] [Related]
24. Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents.
Sakhtianchi R; Darvishi B; Mirzaie Z; Dorkoosh F; Shanehsazzadeh S; Dinarvand R
Pharm Dev Technol; 2019 Nov; 24(9):1063-1075. PubMed ID: 30654677
[TBL] [Abstract][Full Text] [Related]
25. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
[TBL] [Abstract][Full Text] [Related]
26. FOXM1 Aptamer-Polyethylenimine Nanoplatform Coated With Hyaluronic Acid And AS1411 Aptamer For Dual-Targeted Delivery of Doxorubicin And Synergistic Treatment of Tumor Cells.
Khademi Z; Yazdi KS; Ramezani M; Alibolandi M; Rezvani SA; Abnous K; Taghdisi SM
J Pharm Sci; 2024 Mar; ():. PubMed ID: 38432623
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronic Acid-Functionalized Hollow Mesoporous Silica Nanoparticles as pH-Sensitive Nanocarriers for Cancer Chemo-Photodynamic Therapy.
Zhou Y; Chang C; Liu Z; Zhao Q; Xu Q; Li C; Chen Y; Zhang Y; Lu B
Langmuir; 2021 Mar; 37(8):2619-2628. PubMed ID: 33586432
[TBL] [Abstract][Full Text] [Related]
28. Dual targeting of Mg/N doped-carbon quantum dots with folic and hyaluronic acid for targeted drug delivery and cell imaging.
Ziaee N; Farhadian N; Abnous K; Matin MM; Khoshnood A; Yaghoobi E
Biomed Pharmacother; 2023 Aug; 164():114971. PubMed ID: 37295246
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronic Acid-Coated Silica Nanoparticles for Targeted Delivery of Nitric Oxide to Cancer Cells.
Grayton QE; Phan TT; Kussatz CC; Schoenfisch MH
ACS Appl Bio Mater; 2024 Jun; 7(6):3796-3809. PubMed ID: 38776418
[TBL] [Abstract][Full Text] [Related]
30. Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer.
Mansoori-Kermani A; Khalighi S; Akbarzadeh I; Niavol FR; Motasadizadeh H; Mahdieh A; Jahed V; Abdinezhad M; Rahbariasr N; Hosseini M; Ahmadkhani N; Panahi B; Fatahi Y; Mozafari M; Kumar AP; Mostafavi E
Mater Today Bio; 2022 Dec; 16():100349. PubMed ID: 35875198
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe
Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D
Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047
[No Abstract] [Full Text] [Related]
32. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
[TBL] [Abstract][Full Text] [Related]
33. A dual-responsive, hyaluronic acid targeted drug delivery system based on hollow mesoporous silica nanoparticles for cancer therapy.
Huang L; Liu J; Gao F; Cheng Q; Lu B; Zheng H; Xu H; Xu P; Zhang X; Zeng X
J Mater Chem B; 2018 Jul; 6(28):4618-4629. PubMed ID: 32254406
[TBL] [Abstract][Full Text] [Related]
34. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
[TBL] [Abstract][Full Text] [Related]
35. Targeted delivery of epirubicin to cancerous cell using copper sulphide nanoparticle coated with polyarginine and 5TR1 aptamer.
Alizadeh F; Yaghoobi E; Imanimoghadam M; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
J Drug Target; 2023 Dec; 31(9):986-997. PubMed ID: 37869893
[TBL] [Abstract][Full Text] [Related]
36. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
37. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J
Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer.
Kardani A; Yaghoobi H; Alibakhshi A; Khatami M
J Cell Physiol; 2020 Oct; 235(10):6887-6895. PubMed ID: 32003016
[TBL] [Abstract][Full Text] [Related]
39. A multi-storey DNA nanostructure containing doxorubicin and AS1411 aptamer for targeting breast cancer cells.
Yaghoobi E; Zavvar T; Ramezani M; Alibolandi M; Rahimzadeh Oskuei S; Zahiri M; Alinezhad Nameghi M; Abnous K; Taghdisi SM
J Drug Target; 2022 Dec; 30(10):1106-1112. PubMed ID: 35736221
[TBL] [Abstract][Full Text] [Related]
40. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
